-
The Layout of Inhalation Formulations in the Chinese Market (I)
PharmaSources/zhulikou431
June 24, 2020
Inhalation formulations are a dosage form with high technical barriers, with relatively few pharmaceutical enterprises entering this field at the beginning.
-
entrinsic bioscience Secures U.S. Patent Grant for Breakthrough Respiratory Disease Program
prnewswire
October 16, 2020
entrinsic bioscience (EBS), a company pioneering a next generation protein modulation technology, announced that it has been granted U.S. Patent No. (USPN) 10,758,507 ('507 patent) for novel therapeutic formulations in the treatment of a range of ...
-
Lupin ties up with Omron Healthcare
expresspharma
June 15, 2020
Medical device maker Omron Healthcare India has joined hands with pharma firm Lupin to strengthen respiratory disease management facilities, focussing on asthma and chronic obstructive pulmonary disease patients.
-
Sugar could be sweet solution to respiratory disease
worldpharmanews
April 03, 2019
Restriction or inhalation of common sugar could one day treat a range of respiratory diseases, according to new research led by University of Manchester biologists.
-
AstraZeneca and Circassia Enter Strategic Collaboration in Respiratory Disease
americanpharmaceuticalreview
March 20, 2017
AstraZeneca has entered a strategic collaboration with Circassia Pharmaceuticals plc, a respiratory biopharmaceutical company, for the development and commercialisation of Tudorza and Duaklir* in the US.
-
Charles River, Chiesi Extend Drug Discovery Alliance
contractpharma
March 14, 2017
Will provide integrated drug discovery services to help identify and test Chiesi’s candidates